Agency classClass IIOur severity:Severe FDA (Drugs)·D-0007-2027·Announced 2026-10-14

K.C. Pharmaceuticals Recalls Good Sense Eye Drops for Sterility Concerns

K.C. Pharmaceuticals is recalling Good Sense Eye Drops Original Formula due to a lack of assurance of sterility. The recall affects 1,025,448 cartons distributed nationwide.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II due to a lack of assurance of sterility in eye drops. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

K.C. Pharmaceuticals, Inc. is recalling Good Sense Eye Drops Original Formula (Tetrahydrozoline HCl 0.05%) because of a lack of assurance of sterility. The product is a sterile eye drop intended for redness relief. The recall involves 1,025,448 cartons of the 0.5 fl oz (15 mL) size.

The affected product is distributed under multiple brand names, including Good Sense, Best Choice, Discount Drug Mart, H.E.B, Harris Teeter, Circle K, Lil' DrugStore, Quality Choice, TopCare, Equate, Walgreens, and Kroger. The recall covers products with various lot numbers and expiration dates ranging from 11/30/2026 to 12/31/2027. The distribution pattern is US Nationwide.

Consumers should stop using the recalled product and return it to the place of purchase for a refund. The FDA classifies this as a Class II recall, indicating that use of or exposure to the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

The recalled product

Product: GOODSENSE EYE DROPS ORIGINAL FORMULA (TETRAHYDROZOLINE HCL)
Brand: GOODSENSE EYE DROPS ORIGINAL FORMULA
Manufacturer: K.C. Pharmaceuticals, Inc.
Category: Drug — Ophthalmic
Hazard: sterility
Affected units: 1,025,448

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

Lot: a) RG24N02
Exp.: 11/30/2026
b) RG25K04
Exp.: 09/30/2027
c) RG24N02
RG25D01
Exp.: 04/30/2027
RG25D02
RG25K02
RG25K03
RG25N02
Exp.: 11/30/2027
d) RG24N02
e) RG25K04
f) RG24N02
RG25K04
RG25N03
g) RG24N02
RG25K05
h) RG25K05

UPCs (11)

0180410000156
0635515903777
0194346053582
070038470113
093351011573
041220437474
072036713025
366715683243
036800036390
311917200736
011110385970

Distribution

Distributed nationwide across the United States.

Same brand · GOODSENSE EYE DROPS ORIGINAL FORMULA

High
GoodSense original formula eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-08

Same manufacturer · K.C. Pharmaceuticals, Inc.

See all →

Severe
K.C. Pharmaceuticals Recalls Leader Ultra Lubricating Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
K.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
K.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
K.C. Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
Good Sense Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14

Same hazard · sterility